StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.83−0.31 (-4.34%)

Close on Nov 17, 2026Market cap $133.03MP/E –Yield –

Moleculin Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Moleculin Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$25.36M. For fiscal 2025 it was -$22.74M. The highest annual figure on record is -$3.77M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.74M–
FY2024Dec 31, 2024-$23.86M–
FY2023Dec 31, 2023-$23.59M–
FY2022Dec 31, 2022-$27.64M–
FY2021Dec 31, 2021-$18.95M–
FY2020Dec 31, 2020-$17.77M–
FY2019Dec 31, 2019-$17.20M–
FY2018Dec 31, 2018-$12.20M–
FY2017Dec 31, 2017-$7.32M–
FY2016Dec 31, 2016-$3.77M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.66M–
Q1 FY2026Mar 31, 2026-$6.11M–
Q4 FY2025Dec 31, 2025-$5.37M–
Q3 FY2025Sep 30, 2025-$7.22M–
Q2 FY2025Jun 30, 2025-$5.58M–
Q1 FY2025Mar 31, 2025-$4.56M–
Q4 FY2024Dec 31, 2024-$5.08M–
Q3 FY2024Sep 30, 2024-$6.11M–
Q2 FY2024Jun 30, 2024-$5.95M–
Q1 FY2024Mar 31, 2024-$6.72M–
Q4 FY2023Dec 31, 2023-$4.90M–
Q3 FY2023Sep 30, 2023-$7.55M–
Q2 FY2023Jun 30, 2023-$5.13M–
Q1 FY2023Mar 31, 2023-$6.02M–
Q4 FY2022Dec 31, 2022-$7.26M–
Q3 FY2022Sep 30, 2022-$7.58M–
Q2 FY2022Jun 30, 2022-$8.00M–
Q1 FY2022Mar 31, 2022-$4.81M–
Q4 FY2021Dec 31, 2021-$4.26M–
Q3 FY2021Sep 30, 2021-$4.29M–
Q2 FY2021Jun 30, 2021-$6.78M–
Q1 FY2021Mar 31, 2021-$3.62M–
Q4 FY2020Dec 31, 2020-$3.12M–
Q3 FY2020Sep 30, 2020-$5.37M–
Q2 FY2020Jun 30, 2020-$4.93M–
Q1 FY2020Mar 31, 2020-$4.34M–
Q4 FY2019Dec 31, 2019-$4.68M–
Q3 FY2019Sep 30, 2019-$3.33M–
Q2 FY2019Jun 30, 2019-$5.35M–
Q1 FY2019Mar 31, 2019-$3.85M–
Q4 FY2018Dec 31, 2018-$3.11M–
Q3 FY2018Sep 30, 2018-$2.82M–
Q2 FY2018Jun 30, 2018-$3.47M–
Q1 FY2018Mar 31, 2018-$2.81M–
Q4 FY2017Dec 31, 2017-$2.39M–
Q3 FY2017Sep 30, 2017-$1.61M–
Q4 FY2016Dec 31, 2016-$1.17M–
Q3 FY2016Sep 30, 2016-$951.00K–
Q2 FY2016Jun 30, 2016-$1.36M–

More Moleculin Biotech figures

See a number that looks wrong?